Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis

Cancer Research

Volumn 61, Issue 16, 2001, Pages 6248-6254

  Koga, Kazunari ^a   Todaka, Tatemi ^a   Morioka, Motohiro ^a   Hamada, Jun ichiro ^a   Kai, Yutaka ^a   Yano, Shigetoshi ^a   Okamura, Akira ^a   Ushio, Yukitaka ^a   Takakura, Nobuyuki ^a   Suda, Toshio ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; ANGIOPOIETIN 2; MESSENGER RNA; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION FUNCTION; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; ANGIOPOIETIN-2; BRAIN NEOPLASMS; CELL HYPOXIA; CHILD; FEMALE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN BIOSYNTHESIS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0035881887     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis
2. The role of vascular endothelial growth factor in pathological angiogenesis
3. Angiogenesis in cancer, vascular, rheumatoid and other disease
4. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
5. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
6. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
7. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
8. Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system
9. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
10. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization
11. Angiopoietin-1 induces sprouting angiogenesis in vitro
12. Blood vessel formation: What is its molecular basis?
13. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis
14. In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis
15. Is angiopoietin-2 necessary for the initiation of tumor angiogenesis?
16. The new WHO classification of brain tumours
17. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
18. Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms
19. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2
20. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
21. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
22. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
23. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia
24. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis
25. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
26. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells
27. Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene
28. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit
29. 2-dependent degradation domain via the ubiquitin-proteasome pathway
30. Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma
31. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
32. PDGF, TGF-β, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate
33. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice
34. An activated form of transforming growth factor β is produced by cocultures of endothelial cells and pericytes
35. A plasticity window for blood vessel remodeling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF
36. Signaling vascular morphogenesis and maintenance
37. Pericytes in the microvasculature
38. Glioblastoma
39. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia
40. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C
41. Tie2 receptor expression is stimulated by hypoxia and proinflammatory cytokines in human endothelial cells
42. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
43. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
44. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo
45. Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth
46. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2